Driving reinvestment in R&D for antibiotics and advocating their responsible use

DRIVE-AB PROJECT TEAM

NAME SURNAME ORGANISATION WORK STREAM
Stephen Harbarth University of Geneva Coordination of DRIVE-AB and WP3A leader
Inge Gyssens University Medical Centre, Nijmegen WP1A leader
Marlies Hulscher Radboud University Medical Centre, Nijmegen WP1A leader
Jeroen Schouten Radboud University Medical Centre, Nijmegen Partner in WP1A
Herman Goossens University of Antwerp Partner in WP1A
Niels Adriaenssens University of Antwerp Partner in WP1A
Benedikt Huttner University of Geneva Partner in WP1A
Céline Pulcini Nice University Hospital Partner in WP1A
Vera Vlahović-Palčevski Univerisity Hospital Rijeka, Croatia Partner in WP1A
Nicholas Brown British Society for Antimicrobial Chemotherapy Partner in WP1A and WP3B
Laura Piddock British Society for Antimicrobial Chemotherapy Partner in WP1A and WP3B
Tracey Guise British Society for Antimicrobial Chemotherapy Partner in WP1A and WP3B
Yehuda Carmeli Tel Aviv Sourasky Medical Center WP1B Leader
Evelina Tacconelli University of Tüebingen Partner in WP1B
Ramanan Laxminarayan London School of Tropical Medicine and Hygiene WP1C Leader
Timo Goeschl Heidelberg University Partner in WP1C
Justus Wesseler Technical University Munich Partner in WP1C
John-Arne Røttingen Norwegian Institute of Public Health Co-leader of WP2
Otto Cars Uppsala University Co-leader of WP2
Anna Zorzet Uppsall Partner in WP2
Rifat Atun Imperial College London Partner in WP2
Francesco Ciabuschi University of Uppsala Partner in WP2
Enrico Baraldi University of Uppsala Partner in WP2
Steve McKeever University of Uppsala Partner in WP2
Elias Mossialos London School of Economics Partner in WP2
Chantal Morel London School of Economics and University of Geneva Partner in WP2
Suzanne Edwards University of Geneva Partner in WP2
Christine Årdal Norwegian Institute of Public Health Partner in WP2
Steven Hoffman Norwegian Institute of Public Health Partner in WP2
Dimitrios Gouglas Norwegian Institute of Public Health Partner in WP2
Ursula Theuretzbacher CEFAIA WP3B Leader
David Heymann Chatham House Partner in WP3B
Charles Clift Chatham House Partner in WP3B
Brigitte Nolet Roche, Head of Global Public Policy Co-leader of WP3B
Ka Lumb Roche, Head of Global Pricing and Market Access, Immunology, Infectious Diseases and Ophthalmology Participant in WP1C and WP2